One of the important therapeutic goals of GBM management is to achieve steroid independence, and using histopathology and CD31 and αvβ3 integrin IHC we show that arginine depletion greatly reduces vasogenic edema and neovascularization. This evidence concerns the gene PECAM1 and glioblastoma.